GL1X · GenesisL1 explorer

MolNFT v1 · #167507 · protein

USP7 in complex with ligand compound 18

6VN2 · Ubiquitin carboxyl-terminal hydrolase 7: “USP7 in complex with ligand compound 18”. X-ray diffraction, 1 ligand (R44), 7 pockets (best druggability 0.74). MolNFT v1 #167507 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6VN2
Type
protein
Length
678 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ubiquitin carboxyl-terminal hydrolase 7
EC
3.4.19.12
UniProt
Q93009
Ligands
R44
Pockets
7 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUbiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12)protein34134% helix, 27% strandQ93009
BUbiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12)protein33735% helix, 27% strandQ93009

Ligands and binding sites

  • R44 · 1-({7-[(2R)-5-chloro-2-(piperazine-1-carbonyl)-2,3-dihydro-1-benzofuran-7-yl]thieno[3,2-b]pyridin-2-yl}methyl)-1H-pyrrole-2,5-dione · ligand · 2 copies · chains A, B
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110790.740.7782ACT
22660.690.8430R44
32240.670.8424R44
41200.440.7721empty
5580.430.8319empty

Interfaces

1 interface between chains.

  • A–B · 466 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 6VN2 · USP7 in complex with ligand compound 18 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.